AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
INCOME : | |||
Gross Sales | ₹1,945 Cr | ₹1,200 Cr | - |
Sales | ₹1,936 Cr | ₹1,192 Cr | - |
Job Work/ Contract Receipts | - | - | - |
Processing Charges / Service Income | - | - | - |
Revenue from property development | - | - | - |
Other Operational Income | ₹9.23 Cr | ₹7.91 Cr | - |
Less: Excise Duty | - | - | - |
Net Sales | ₹1,945 Cr | ₹1,200 Cr | - |
EXPENDITURE : | |||
Increase/Decrease in Stock | ₹-125 Cr | ₹-49 Cr | - |
Raw Material Consumed | ₹1,141 Cr | ₹687 Cr | - |
Opening Raw Materials | ₹191 Cr | - | - |
Purchases Raw Materials | ₹861 Cr | ₹714 Cr | - |
Closing Raw Materials | ₹191 Cr | ₹191 Cr | - |
Other Direct Purchases / Brought in cost | ₹281 Cr | ₹163 Cr | - |
Other raw material cost | - | - | - |
Power & Fuel Cost | ₹165 Cr | ₹90 Cr | - |
Electricity & Power | ₹71 Cr | ₹42 Cr | - |
Oil, Fuel & Natural gas | ₹90 Cr | ₹46 Cr | - |
Coals etc | - | - | - |
Other power & fuel | ₹4.35 Cr | ₹2.49 Cr | - |
Employee Cost | ₹130 Cr | ₹85 Cr | - |
Salaries, Wages & Bonus | ₹116 Cr | ₹85 Cr | - |
Contributions to EPF & Pension Funds | ₹8.15 Cr | ₹0.28 Cr | - |
Workmen and Staff Welfare Expenses | ₹5.18 Cr | ₹0.34 Cr | - |
Other Employees Cost | - | - | - |
Other Manufacturing Expenses | ₹216 Cr | ₹146 Cr | - |
Sub-contracted / Out sourced services | - | - | - |
Processing Charges | ₹8.91 Cr | ₹6.04 Cr | - |
Repairs and Maintenance | ₹35 Cr | ₹22 Cr | - |
Packing Material Consumed | ₹20 Cr | ₹13 Cr | - |
Other Mfg Exp | ₹152 Cr | ₹105 Cr | - |
General and Administration Expenses | ₹17 Cr | ₹8.13 Cr | ₹0.01 Cr |
Rent , Rates & Taxes | ₹1.07 Cr | ₹0.12 Cr | - |
Insurance | ₹9.00 Cr | ₹6.50 Cr | - |
Printing and stationery | - | - | - |
Professional and legal fees | ₹1.25 Cr | ₹0.39 Cr | - |
Traveling and conveyance | ₹1.88 Cr | ₹0.95 Cr | - |
Other Administration | ₹3.44 Cr | ₹0.16 Cr | ₹0.01 Cr |
Selling and Distribution Expenses | ₹58 Cr | ₹27 Cr | - |
Advertisement & Sales Promotion | ₹5.16 Cr | - | - |
Sales Commissions & Incentives | ₹27 Cr | ₹5.97 Cr | - |
Freight and Forwarding | ₹24 Cr | ₹21 Cr | - |
Handling and Clearing Charges | - | - | - |
Other Selling Expenses | ₹2.52 Cr | ₹0.41 Cr | - |
Miscellaneous Expenses | ₹1.53 Cr | ₹0.34 Cr | - |
Bad debts /advances written off | - | - | - |
Provision for doubtful debts | - | - | - |
Losson disposal of fixed assets(net) | ₹0.39 Cr | - | - |
Losson foreign exchange fluctuations | - | - | - |
Losson sale of non-trade current investments | - | - | - |
Other Miscellaneous Expenses | ₹1.14 Cr | ₹0.34 Cr | - |
Less: Expenses Capitalised | - | - | - |
Total Expenditure | ₹1,603 Cr | ₹995 Cr | ₹0.01 Cr |
Operating Profit (Excl OI) | ₹342 Cr | ₹205 Cr | ₹-0.01 Cr |
Other Income | ₹2.32 Cr | ₹4.19 Cr | - |
Interest Received | ₹0.94 Cr | ₹0.01 Cr | - |
Dividend Received | ₹1.25 Cr | ₹2.48 Cr | - |
Profit on sale of Fixed Assets | ₹-0.06 Cr | ₹0.02 Cr | - |
Profits on sale of Investments | - | - | - |
Provision Written Back | - | - | - |
Foreign Exchange Gains | - | - | - |
Others | ₹0.19 Cr | ₹1.68 Cr | - |
Operating Profit | ₹344 Cr | ₹209 Cr | ₹-0.01 Cr |
Interest | ₹21 Cr | ₹12 Cr | - |
InterestonDebenture / Bonds | - | - | - |
Interest on Term Loan | - | - | - |
Intereston Fixed deposits | - | - | - |
Bank Charges etc | ₹1.42 Cr | ₹12 Cr | - |
Other Interest | ₹20 Cr | ₹0.34 Cr | - |
PBDT | ₹323 Cr | ₹197 Cr | ₹-0.01 Cr |
Depreciation | ₹63 Cr | ₹42 Cr | - |
Profit Before Taxation & Exceptional Items | ₹261 Cr | ₹155 Cr | ₹-0.01 Cr |
Exceptional Income / Expenses | - | - | - |
Profit Before Tax | ₹261 Cr | ₹155 Cr | ₹-0.01 Cr |
Provision for Tax | ₹67 Cr | ₹33 Cr | - |
Current Income Tax | ₹59 Cr | ₹27 Cr | - |
Deferred Tax | ₹8.17 Cr | ₹4.68 Cr | - |
Other taxes | - | ₹1.13 Cr | - |
Profit After Tax | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr |
Extra items | - | - | - |
Minority Interest | - | - | - |
Share of Associate | - | - | - |
Other Consolidated Items | - | - | - |
Consolidated Net Profit | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr |
Adjustments to PAT | - | - | - |
Profit Balance B/F | ₹717 Cr | ₹-0.02 Cr | ₹-0.02 Cr |
Appropriations | ₹911 Cr | ₹122 Cr | ₹-0.02 Cr |
General Reserves | ₹1.90 Cr | ₹1.48 Cr | - |
Proposed Equity Dividend | - | - | - |
Corporate dividend tax | - | - | - |
Other Appropriation | ₹1.31 Cr | ₹-596 Cr | - |
Equity Dividend % | ₹40.00 | - | - |
Earnings Per Share | ₹21.35 | ₹4,890.04 | ₹-0.18 |
Adjusted EPS | ₹21.35 | ₹4,890.04 | ₹-0.18 |
Compare Income Statement of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,494.0 Cr | 20.2% | 31.8% | 43.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 20.2% |
31.8% |
43.3% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses